articleThe LancetJan 1, 2003Closed access

CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL

Abstract

No abstract available for this paper.

Citation impact

1,045
total citations
FWCI
55.12
Percentile
100%
References
0
Citations per year

Authors

9

Topics & keywords

Keywords
  • Candesartan
  • Charm (quantum number)
  • Heart failure
  • Cardiology
  • Internal medicine
  • Medicine
  • Ventricular function
  • Angiotensin II
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.